instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Pneumonia'? | Pleural effusion as a rare presentation of foreign body aspiration.
Unsuspected, non-asphyxiating, aspirated foreign body often masquerades as unresolved pneumonia, bronchiolitis or bronchial asthma. We report herein an 82-year-old, male patient with pleural effusion. Although the patient received the diagnosis of hear... | Fatal | ReactionOutcome | CC BY-NC-ND | 34401264 | 20,592,816 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Invasion of small cell lung cancer into the limbic system from leptomeningeal metastases.
The diagnosis of leptomeningeal metastases is sometimes difficult when the cytology of cerebrospinal fluid is negative. We report a rare case of leptomeningeal metastases that required differentiation from paraneoplastic limbic en... | IMMUNE GLOBULIN NOS, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34401265 | 19,778,776 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to meninges'. | Invasion of small cell lung cancer into the limbic system from leptomeningeal metastases.
The diagnosis of leptomeningeal metastases is sometimes difficult when the cytology of cerebrospinal fluid is negative. We report a rare case of leptomeningeal metastases that required differentiation from paraneoplastic limbic en... | IMMUNE GLOBULIN NOS, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34401265 | 19,778,776 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Invasion of small cell lung cancer into the limbic system from leptomeningeal metastases.
The diagnosis of leptomeningeal metastases is sometimes difficult when the cytology of cerebrospinal fluid is negative. We report a rare case of leptomeningeal metastases that required differentiation from paraneoplastic limbic en... | IMMUNE GLOBULIN NOS, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34401265 | 19,778,776 | 2021 |
What was the administration route of drug 'IMMUNE GLOBULIN NOS'? | Invasion of small cell lung cancer into the limbic system from leptomeningeal metastases.
The diagnosis of leptomeningeal metastases is sometimes difficult when the cytology of cerebrospinal fluid is negative. We report a rare case of leptomeningeal metastases that required differentiation from paraneoplastic limbic en... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34401265 | 19,778,776 | 2021 |
What was the outcome of reaction 'Metastases to meninges'? | Invasion of small cell lung cancer into the limbic system from leptomeningeal metastases.
The diagnosis of leptomeningeal metastases is sometimes difficult when the cytology of cerebrospinal fluid is negative. We report a rare case of leptomeningeal metastases that required differentiation from paraneoplastic limbic en... | Fatal | ReactionOutcome | CC BY-NC-ND | 34401265 | 19,778,776 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Obstructive jaundice, a rare presentation of lung cancer: A case report.
Lung cancer metastases to the pancreas are rare but potentially life-threatening. Oftentimes, the presence of symptoms is indicative of extensive disease burden. This report describes a case of primary lung adenocarcinoma metastasizing to the head... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34401271 | 20,977,312 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Obstructive jaundice, a rare presentation of lung cancer: A case report.
Lung cancer metastases to the pancreas are rare but potentially life-threatening. Oftentimes, the presence of symptoms is indicative of extensive disease burden. This report describes a case of primary lung adenocarcinoma metastasizing to the head... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34401271 | 20,940,783 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Obstructive jaundice, a rare presentation of lung cancer: A case report.
Lung cancer metastases to the pancreas are rare but potentially life-threatening. Oftentimes, the presence of symptoms is indicative of extensive disease burden. This report describes a case of primary lung adenocarcinoma metastasizing to the head... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34401271 | 20,977,312 | 2021 |
What was the outcome of reaction 'Sepsis'? | Obstructive jaundice, a rare presentation of lung cancer: A case report.
Lung cancer metastases to the pancreas are rare but potentially life-threatening. Oftentimes, the presence of symptoms is indicative of extensive disease burden. This report describes a case of primary lung adenocarcinoma metastasizing to the head... | Fatal | ReactionOutcome | CC BY-NC-ND | 34401271 | 20,977,312 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report.
Hematological immune-related adverse events (hem-irAEs) related to immunotherapy have not been extensively characterized, and there is no report of neutropenia caused by atezolizumab administration. Herein, we rep... | ATEZOLIZUMAB, BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34401279 | 19,797,038 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report.
Hematological immune-related adverse events (hem-irAEs) related to immunotherapy have not been extensively characterized, and there is no report of neutropenia caused by atezolizumab administration. Herein, we rep... | ATEZOLIZUMAB, BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34401279 | 19,797,038 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report.
Hematological immune-related adverse events (hem-irAEs) related to immunotherapy have not been extensively characterized, and there is no report of neutropenia caused by atezolizumab administration. Herein, we rep... | ATEZOLIZUMAB, BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34401279 | 19,797,038 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report.
Hematological immune-related adverse events (hem-irAEs) related to immunotherapy have not been extensively characterized, and there is no report of neutropenia caused by atezolizumab administration. Herein, we rep... | ATEZOLIZUMAB, BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34401279 | 19,797,038 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report.
Hematological immune-related adverse events (hem-irAEs) related to immunotherapy have not been extensively characterized, and there is no report of neutropenia caused by atezolizumab administration. Herein, we rep... | ATEZOLIZUMAB, BEVACIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34401279 | 19,797,038 | 2021 |
What was the administration route of drug 'ATEZOLIZUMAB'? | Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report.
Hematological immune-related adverse events (hem-irAEs) related to immunotherapy have not been extensively characterized, and there is no report of neutropenia caused by atezolizumab administration. Herein, we rep... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 34401279 | 19,797,038 | 2021 |
What was the administration route of drug 'BEVACIZUMAB'? | Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report.
Hematological immune-related adverse events (hem-irAEs) related to immunotherapy have not been extensively characterized, and there is no report of neutropenia caused by atezolizumab administration. Herein, we rep... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 34401279 | 19,797,038 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Alectinib re-challenge in small cell lung cancer transformation after chemotherapy failure in a patient with ALK-positive lung cancer: A case report.
Small cell lung cancer (SCLC) transformation is a rare resistance mechanism to anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs), for which cytotoxic chemo... | AMRUBICIN, CISPLATIN, DOCETAXEL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, PEMETREXED | DrugsGivenReaction | CC BY | 34401280 | 20,493,827 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to central nervous system'. | Alectinib re-challenge in small cell lung cancer transformation after chemotherapy failure in a patient with ALK-positive lung cancer: A case report.
Small cell lung cancer (SCLC) transformation is a rare resistance mechanism to anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs), for which cytotoxic chemo... | AMRUBICIN, CISPLATIN, DOCETAXEL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, PEMETREXED | DrugsGivenReaction | CC BY | 34401280 | 20,493,827 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Alectinib re-challenge in small cell lung cancer transformation after chemotherapy failure in a patient with ALK-positive lung cancer: A case report.
Small cell lung cancer (SCLC) transformation is a rare resistance mechanism to anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs), for which cytotoxic chemo... | AMRUBICIN, CISPLATIN, DOCETAXEL, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, PEMETREXED | DrugsGivenReaction | CC BY | 34401280 | 20,493,827 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Asymptomatic occlusive retinal vasculitis in newly diagnosed active tuberculosis.
Worldwide, tuberculosis is the leading cause of death from an infectious disease. Ocular involvement can cause significant and permanent vision loss. Ocular manifestations of tuberculosis often present with visual symptoms. Asymptomatic o... | PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401294 | 20,343,354 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cryptococcosis'. | Isolated pulmonary cryptococcosis in a patient with Crohn's disease treated with infliximab: A case report and literature review.
Tumor necrosis factor-alpha (TNF-α) inhibitors are widely used to treat various inflammatory conditions, where they have demonstrated excellent efficacy and tolerability. However, increased ... | METHOTREXATE, PREDNISOLONE | DrugsGivenReaction | CC BY | 34401295 | 20,359,520 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Isolated pulmonary cryptococcosis in a patient with Crohn's disease treated with infliximab: A case report and literature review.
Tumor necrosis factor-alpha (TNF-α) inhibitors are widely used to treat various inflammatory conditions, where they have demonstrated excellent efficacy and tolerability. However, increased ... | METHOTREXATE, PREDNISOLONE | DrugsGivenReaction | CC BY | 34401295 | 20,359,520 | 2021 |
What was the administration route of drug 'FLUCONAZOLE'? | Isolated pulmonary cryptococcosis in a patient with Crohn's disease treated with infliximab: A case report and literature review.
Tumor necrosis factor-alpha (TNF-α) inhibitors are widely used to treat various inflammatory conditions, where they have demonstrated excellent efficacy and tolerability. However, increased ... | Oral | DrugAdministrationRoute | CC BY | 34401295 | 19,752,748 | 2021 |
What was the administration route of drug 'INFLIXIMAB'? | Isolated pulmonary cryptococcosis in a patient with Crohn's disease treated with infliximab: A case report and literature review.
Tumor necrosis factor-alpha (TNF-α) inhibitors are widely used to treat various inflammatory conditions, where they have demonstrated excellent efficacy and tolerability. However, increased ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34401295 | 19,752,748 | 2021 |
What was the dosage of drug 'INFLIXIMAB'? | Isolated pulmonary cryptococcosis in a patient with Crohn's disease treated with infliximab: A case report and literature review.
Tumor necrosis factor-alpha (TNF-α) inhibitors are widely used to treat various inflammatory conditions, where they have demonstrated excellent efficacy and tolerability. However, increased ... | CUMULATIVE DOSE: 5 DOSAGE FORM | DrugDosageText | CC BY | 34401295 | 20,316,761 | 2021 |
What was the outcome of reaction 'Cryptococcosis'? | Isolated pulmonary cryptococcosis in a patient with Crohn's disease treated with infliximab: A case report and literature review.
Tumor necrosis factor-alpha (TNF-α) inhibitors are widely used to treat various inflammatory conditions, where they have demonstrated excellent efficacy and tolerability. However, increased ... | Recovering | ReactionOutcome | CC BY | 34401295 | 20,359,520 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Catastrophic right-sided Candida empyema from spontaneous esophageal perforation.
Right-sided empyema secondary to esophageal rupture are rare but reported in the medical literature. We describe an atypical CASE of right-sided empyema with Candida Tropicalis, Candida Glabrata, and Staphylococcus lugdenensis leading to ... | CASPOFUNGIN ACETATE, MEROPENEM | DrugsGivenReaction | CC BY-NC-ND | 34401296 | 20,321,164 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level increased'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | LEFLUNOMIDE, LEUCOVORIN, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 19,685,419 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug metabolite level high'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | LEFLUNOMIDE, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'False positive investigation result'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | ALBUMIN HUMAN, CEFEPIME HYDROCHLORIDE, LEFLUNOMIDE, LEUCOVORIN, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 20,385,985 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immunodeficiency'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | LEFLUNOMIDE, LEUCOVORIN CALCIUM, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incorrect dose administered'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | LEFLUNOMIDE, LEUCOVORIN CALCIUM, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nasal inflammation'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | LEFLUNOMIDE, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rales'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | LEFLUNOMIDE, LEUCOVORIN CALCIUM, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhonchi'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | LEFLUNOMIDE, LEUCOVORIN CALCIUM, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stomatitis'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | LEFLUNOMIDE, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxic encephalopathy'. | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | LEFLUNOMIDE, LEUCOVORIN, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401304 | 19,685,419 | 2021 |
What was the outcome of reaction 'Accidental overdose'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovered | ReactionOutcome | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
What was the outcome of reaction 'C-reactive protein increased'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovering | ReactionOutcome | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
What was the outcome of reaction 'Drug metabolite level high'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovering | ReactionOutcome | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
What was the outcome of reaction 'Immunodeficiency'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovered | ReactionOutcome | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
What was the outcome of reaction 'Incorrect dose administered'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovered | ReactionOutcome | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
What was the outcome of reaction 'Lymphopenia'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovering | ReactionOutcome | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
What was the outcome of reaction 'Nasal inflammation'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovering | ReactionOutcome | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
What was the outcome of reaction 'Neutropenia'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovered | ReactionOutcome | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
What was the outcome of reaction 'Pneumonitis'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovering | ReactionOutcome | CC BY-NC-ND | 34401304 | 20,368,242 | 2021 |
What was the outcome of reaction 'Rales'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovered | ReactionOutcome | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
What was the outcome of reaction 'Red blood cell sedimentation rate increased'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovering | ReactionOutcome | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
What was the outcome of reaction 'Rhonchi'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovered | ReactionOutcome | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
What was the outcome of reaction 'Stomatitis'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovering | ReactionOutcome | CC BY-NC-ND | 34401304 | 20,361,179 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from a... | Recovered | ReactionOutcome | CC BY-NC-ND | 34401304 | 19,601,792 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Mitomycin induced pulmonary veno-occlusive disease.
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules. Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxici... | CARBOPLATIN, FLUOROURACIL, MITOMYCIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 34401312 | 19,785,723 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary veno-occlusive disease'. | Mitomycin induced pulmonary veno-occlusive disease.
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules. Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxici... | CARBOPLATIN, FLUOROURACIL, MITOMYCIN, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 34401312 | 19,775,736 | 2021 |
What was the dosage of drug 'CARBOPLATIN'? | Mitomycin induced pulmonary veno-occlusive disease.
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules. Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxici... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34401312 | 19,775,736 | 2021 |
What was the dosage of drug 'FLUOROURACIL'? | Mitomycin induced pulmonary veno-occlusive disease.
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules. Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxici... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34401312 | 19,775,736 | 2021 |
What was the dosage of drug 'MITOMYCIN'? | Mitomycin induced pulmonary veno-occlusive disease.
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules. Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxici... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34401312 | 19,775,736 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | Mitomycin induced pulmonary veno-occlusive disease.
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules. Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxici... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34401312 | 19,775,736 | 2021 |
What was the outcome of reaction 'Pulmonary veno-occlusive disease'? | Mitomycin induced pulmonary veno-occlusive disease.
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules. Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with documented lung toxici... | Fatal | ReactionOutcome | CC BY-NC-ND | 34401312 | 19,785,723 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Candida infection'. | Pulmonary talcosis in the setting of cosmetic talcum powder use.
Pulmonary talcosis is a rare pneumoconiosis that is difficult to diagnose and may progress to debilitating lung disease. Four types of talcosis are described in literature: talc-silicosis and talc-asbestosis secondary to inhalation in industry workers and... | PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34401315 | 20,167,649 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Budd-Chiari syndrome'. | Budd-Chiari syndrome caused by latent hepatic metastasis from a thymoma.
A 34-year-old woman visited our hospital because she had had abdominal bloating for 2 months. She had been diagnosed with invasive thymoma (WHO pathological type B2), for which she had undergone chemotherapy and total thymectomy 10 years previousl... | CISPLATIN, DOXORUBICIN, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34401316 | 19,806,661 | 2021 |
What is the weight of the patient? | Budd-Chiari syndrome caused by latent hepatic metastasis from a thymoma.
A 34-year-old woman visited our hospital because she had had abdominal bloating for 2 months. She had been diagnosed with invasive thymoma (WHO pathological type B2), for which she had undergone chemotherapy and total thymectomy 10 years previousl... | 70 kg. | Weight | CC BY | 34401316 | 19,806,661 | 2021 |
What was the outcome of reaction 'Budd-Chiari syndrome'? | Budd-Chiari syndrome caused by latent hepatic metastasis from a thymoma.
A 34-year-old woman visited our hospital because she had had abdominal bloating for 2 months. She had been diagnosed with invasive thymoma (WHO pathological type B2), for which she had undergone chemotherapy and total thymectomy 10 years previousl... | Recovering | ReactionOutcome | CC BY | 34401316 | 19,806,661 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | AMOXICILLIN\CLAVULANIC ACID, AMPICILLIN SODIUM\SULBACTAM SODIUM, AZITHROMYCIN, FAVIPIRAVIR, REMDESIVIR | DrugsGivenReaction | CC BY | 34401329 | 20,034,932 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19 pneumonia'. | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | AMOXICILLIN\CLAVULANIC ACID, AMPICILLIN SODIUM\SULBACTAM SODIUM, AZITHROMYCIN, FAVIPIRAVIR, REMDESIVIR | DrugsGivenReaction | CC BY | 34401329 | 20,034,932 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oxygen saturation decreased'. | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | AMOXICILLIN\CLAVULANIC ACID, AMPICILLIN SODIUM\SULBACTAM SODIUM, AZITHROMYCIN, FAVIPIRAVIR, REMDESIVIR | DrugsGivenReaction | CC BY | 34401329 | 20,034,932 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus bradycardia'. | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | AMOXICILLIN\CLAVULANIC ACID, AMPICILLIN SODIUM\SULBACTAM SODIUM, AZITHROMYCIN, FAVIPIRAVIR, REMDESIVIR | DrugsGivenReaction | CC BY | 34401329 | 20,034,932 | 2021 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANATE POTASSIUM'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Oral | DrugAdministrationRoute | CC BY | 34401329 | 20,051,103 | 2021 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Oral | DrugAdministrationRoute | CC BY | 34401329 | 20,034,932 | 2021 |
What was the administration route of drug 'AMPICILLIN SODIUM\SULBACTAM SODIUM'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34401329 | 20,034,932 | 2021 |
What was the administration route of drug 'FAVIPIRAVIR'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Oral | DrugAdministrationRoute | CC BY | 34401329 | 19,751,839 | 2021 |
What was the administration route of drug 'REMDESIVIR'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34401329 | 19,754,477 | 2021 |
What was the dosage of drug 'COVID-19 CONVALESCENT PLASMA'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | UNK (2 UNITS) | DrugDosageText | CC BY | 34401329 | 20,050,095 | 2021 |
What was the outcome of reaction 'Atrial fibrillation'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Recovered | ReactionOutcome | CC BY | 34401329 | 20,034,932 | 2021 |
What was the outcome of reaction 'Bradycardia'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Recovered | ReactionOutcome | CC BY | 34401329 | 19,754,477 | 2021 |
What was the outcome of reaction 'COVID-19 pneumonia'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Recovering | ReactionOutcome | CC BY | 34401329 | 20,034,932 | 2021 |
What was the outcome of reaction 'Oxygen saturation decreased'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Recovering | ReactionOutcome | CC BY | 34401329 | 20,034,932 | 2021 |
What was the outcome of reaction 'Sinus bradycardia'? | Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We ... | Recovered | ReactionOutcome | CC BY | 34401329 | 20,034,932 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.
Cytopathic effects and local immune response were analyzed histologically in prostatic cancer (PCa) with in situ herpes simplex virus-thymidine kinase (HSV-tk)/ganciclovir (GCV) gene therapy (GT)... | GANCICLOVIR | DrugsGivenReaction | CC BY-NC-ND | 34401335 | 19,752,799 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.
Cytopathic effects and local immune response were analyzed histologically in prostatic cancer (PCa) with in situ herpes simplex virus-thymidine kinase (HSV-tk)/ganciclovir (GCV) gene therapy (GT)... | GANCICLOVIR | DrugsGivenReaction | CC BY-NC-ND | 34401335 | 19,752,799 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.
Cytopathic effects and local immune response were analyzed histologically in prostatic cancer (PCa) with in situ herpes simplex virus-thymidine kinase (HSV-tk)/ganciclovir (GCV) gene therapy (GT)... | GANCICLOVIR | DrugsGivenReaction | CC BY-NC-ND | 34401335 | 19,752,799 | 2021-07 |
What was the administration route of drug 'GANCICLOVIR'? | Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.
Cytopathic effects and local immune response were analyzed histologically in prostatic cancer (PCa) with in situ herpes simplex virus-thymidine kinase (HSV-tk)/ganciclovir (GCV) gene therapy (GT)... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34401335 | 19,752,799 | 2021-07 |
What was the outcome of reaction 'Pulmonary embolism'? | Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.
Cytopathic effects and local immune response were analyzed histologically in prostatic cancer (PCa) with in situ herpes simplex virus-thymidine kinase (HSV-tk)/ganciclovir (GCV) gene therapy (GT)... | Fatal | ReactionOutcome | CC BY-NC-ND | 34401335 | 19,752,799 | 2021-07 |
What was the outcome of reaction 'Thrombocytopenia'? | Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer.
Cytopathic effects and local immune response were analyzed histologically in prostatic cancer (PCa) with in situ herpes simplex virus-thymidine kinase (HSV-tk)/ganciclovir (GCV) gene therapy (GT)... | Recovered | ReactionOutcome | CC BY-NC-ND | 34401335 | 19,752,799 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma.
To investigate the efficacy of pembrolizumab plus lenvatinib as a second-line or later-line therapy in women with advanced or recurrent uterine carcinosarcoma (UCS).
A single-institution pharmacy database was queried for women ... | LENVATINIB MESYLATE, PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34401435 | 19,685,062 | 2021-08 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma.
To investigate the efficacy of pembrolizumab plus lenvatinib as a second-line or later-line therapy in women with advanced or recurrent uterine carcinosarcoma (UCS).
A single-institution pharmacy database was queried for women ... | 2 CYCLES | DrugDosageText | CC BY-NC-ND | 34401435 | 19,685,062 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deafness bilateral'. | Cisplatin ototoxicity histopathology.
This study investigates the histopathological changes of the cochlea and vestibular end organs of a patient who received cisplatin for Hodgkin's lymphoma. He experienced acute high-frequency sensorineural hearing loss and tinnitus after receiving treatment. Using histopathological ... | CISPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34401512 | 19,607,440 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deafness neurosensory'. | Cisplatin ototoxicity histopathology.
This study investigates the histopathological changes of the cochlea and vestibular end organs of a patient who received cisplatin for Hodgkin's lymphoma. He experienced acute high-frequency sensorineural hearing loss and tinnitus after receiving treatment. Using histopathological ... | CISPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34401512 | 19,607,440 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Cisplatin ototoxicity histopathology.
This study investigates the histopathological changes of the cochlea and vestibular end organs of a patient who received cisplatin for Hodgkin's lymphoma. He experienced acute high-frequency sensorineural hearing loss and tinnitus after receiving treatment. Using histopathological ... | CISPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34401512 | 19,607,440 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tinnitus'. | Cisplatin ototoxicity histopathology.
This study investigates the histopathological changes of the cochlea and vestibular end organs of a patient who received cisplatin for Hodgkin's lymphoma. He experienced acute high-frequency sensorineural hearing loss and tinnitus after receiving treatment. Using histopathological ... | CISPLATIN | DrugsGivenReaction | CC BY-NC-ND | 34401512 | 19,607,440 | 2021-08 |
What was the administration route of drug 'CISPLATIN'? | Cisplatin ototoxicity histopathology.
This study investigates the histopathological changes of the cochlea and vestibular end organs of a patient who received cisplatin for Hodgkin's lymphoma. He experienced acute high-frequency sensorineural hearing loss and tinnitus after receiving treatment. Using histopathological ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34401512 | 19,607,440 | 2021-08 |
What was the outcome of reaction 'Deafness bilateral'? | Cisplatin ototoxicity histopathology.
This study investigates the histopathological changes of the cochlea and vestibular end organs of a patient who received cisplatin for Hodgkin's lymphoma. He experienced acute high-frequency sensorineural hearing loss and tinnitus after receiving treatment. Using histopathological ... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34401512 | 19,607,440 | 2021-08 |
What was the outcome of reaction 'Deafness neurosensory'? | Cisplatin ototoxicity histopathology.
This study investigates the histopathological changes of the cochlea and vestibular end organs of a patient who received cisplatin for Hodgkin's lymphoma. He experienced acute high-frequency sensorineural hearing loss and tinnitus after receiving treatment. Using histopathological ... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34401512 | 19,607,440 | 2021-08 |
What was the outcome of reaction 'Tinnitus'? | Cisplatin ototoxicity histopathology.
This study investigates the histopathological changes of the cochlea and vestibular end organs of a patient who received cisplatin for Hodgkin's lymphoma. He experienced acute high-frequency sensorineural hearing loss and tinnitus after receiving treatment. Using histopathological ... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34401512 | 19,607,440 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatinine increased'. | Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial.
Neoadjuvant radiotherapy with or without chemotherapy decreases the risk of local recurrence after surgery for rectal cancer. Emerging data suggest that diabetic patients on metformin may have improved c... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34401534 | 20,198,293 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cystitis'. | Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial.
Neoadjuvant radiotherapy with or without chemotherapy decreases the risk of local recurrence after surgery for rectal cancer. Emerging data suggest that diabetic patients on metformin may have improved c... | CAPECITABINE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34401534 | 20,198,307 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis'. | Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial.
Neoadjuvant radiotherapy with or without chemotherapy decreases the risk of local recurrence after surgery for rectal cancer. Emerging data suggest that diabetic patients on metformin may have improved c... | CAPECITABINE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34401534 | 20,198,307 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial.
Neoadjuvant radiotherapy with or without chemotherapy decreases the risk of local recurrence after surgery for rectal cancer. Emerging data suggest that diabetic patients on metformin may have improved c... | CAPECITABINE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34401534 | 20,198,306 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial.
Neoadjuvant radiotherapy with or without chemotherapy decreases the risk of local recurrence after surgery for rectal cancer. Emerging data suggest that diabetic patients on metformin may have improved c... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34401534 | 20,198,293 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial.
Neoadjuvant radiotherapy with or without chemotherapy decreases the risk of local recurrence after surgery for rectal cancer. Emerging data suggest that diabetic patients on metformin may have improved c... | CAPECITABINE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34401534 | 20,203,701 | 2021-09 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.